EPISODE · Aug 26, 2021 · 24 MIN
Let's Talk Medtech with PwC's Glenn Hunzinger
from Let’s Talk Medtech
PwC's Glenn Hunzinger stops by to discuss the Pharmaceutical and life sciences deals insights: 2021 midyear outlook report, showcasing the PLS sector returned to normal deal activity with strong deal volume. Plus, Omar Ford, MD+DI's Managing Editor gives his take on the controversial Illumina/Grail merger.
Embed this episode
Ready to play
Let's Talk Medtech with PwC's Glenn Hunzinger
0:00
24:26
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of Let’s Talk Medtech?
This episode is 24 minutes long.
When was this Let’s Talk Medtech episode published?
This episode was published on August 26, 2021.
Can I download this Let’s Talk Medtech episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!